ACLARION, INC. Cost of Revenue
ACLARION, INC. (ACON) reported Cost of Revenue of $16.91 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-06
- ACLARION, INC. cost of revenue for the quarter ending 2026-06-30 was $16.91K, a 19.27% increase year-over-year.
- ACLARION, INC. cost of revenue for the quarter ending 2026-03-31 was $17.39K, a 25.93% decline year-over-year.
- ACLARION, INC. cost of revenue for the quarter ending 2025-12-31 was $16.69K, a 18.82% decline year-over-year.
- ACLARION, INC. cost of revenue for the quarter ending 2025-09-30 was $14.56K, a 31.76% decline year-over-year.
- ACLARION, INC. cost of revenue for fiscal 2025 was $68.90K, a 18.61% decline from fiscal 2024.
- ACLARION, INC. cost of revenue for fiscal 2024 was $84.66K, a 11.79% increase from fiscal 2023.
- ACLARION, INC. cost of revenue for fiscal 2023 was $75.73K, a 15.97% increase from fiscal 2022.
- ACLARION, INC. cost of revenue for fiscal 2022 was $65.30K, a 5.60% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.91K 10-Q · filed 2026-08-06 | $34.30K 10-Q · filed 2026-08-06 | $50.99K derived: sum of 3 quarters · filed 2026-08-06 | $65.55K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $17.39K 10-Q · filed 2026-05-13 | $34.08K derived: sum of 2 quarters · filed 2026-05-13 | $48.63K derived: sum of 3 quarters · filed 2026-05-13 | $62.81K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $31.24K derived: sum of 2 quarters · filed 2026-03-18 | $45.42K derived: sum of 3 quarters · filed 2026-08-06 | $68.90K 10-K · filed 2026-03-18 |
| 2025-09-30 | $14.56K 10-Q · filed 2025-11-12 | $28.73K derived: sum of 2 quarters · filed 2026-08-06 | $52.21K 10-Q · filed 2025-11-12 | $72.77K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.18K 10-Q · filed 2026-08-06 | $37.66K 10-Q · filed 2026-08-06 | $58.21K derived: sum of 3 quarters · filed 2026-08-06 | $79.55K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $23.48K 10-Q · filed 2026-05-13 | $44.03K derived: sum of 2 quarters · filed 2026-05-13 | $65.37K derived: sum of 3 quarters · filed 2026-05-13 | $88.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $20.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $41.89K derived: sum of 2 quarters · filed 2026-03-18 | $65.18K derived: sum of 3 quarters · filed 2026-03-18 | $84.66K 10-K · filed 2026-03-18 |
| 2024-09-30 | $21.33K 10-Q · filed 2025-11-12 | $44.63K derived: sum of 2 quarters · filed 2025-11-12 | $64.10K 10-Q · filed 2025-11-12 | $83.52K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $23.29K 10-Q · filed 2025-08-14 | $42.77K 10-Q · filed 2025-08-14 | $62.19K derived: sum of 3 quarters · filed 2025-08-14 | $81.74K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $19.48K 10-Q · filed 2025-05-15 | $38.89K derived: sum of 2 quarters · filed 2025-05-15 | $58.45K derived: sum of 3 quarters · filed 2025-05-15 | $77.75K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $19.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $38.97K derived: sum of 2 quarters · filed 2025-04-09 | $58.27K derived: sum of 3 quarters · filed 2025-04-09 | $75.73K 10-K · filed 2025-04-09 |
| 2023-09-30 | $19.56K 10-Q · filed 2024-11-14 | $38.86K derived: sum of 2 quarters · filed 2024-11-14 | $56.31K 10-Q · filed 2024-11-14 | $73.60K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $19.30K 10-Q · filed 2024-08-14 | $36.75K 10-Q · filed 2024-08-14 | $54.04K derived: sum of 3 quarters · filed 2024-08-14 | $71.07K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $17.45K 10-Q · filed 2024-05-15 | $34.74K derived: sum of 2 quarters · filed 2024-05-15 | $51.77K derived: sum of 3 quarters · filed 2024-05-15 | $66.02K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $17.29K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $34.32K derived: sum of 2 quarters · filed 2024-03-28 | $48.57K derived: sum of 3 quarters · filed 2024-03-28 | $65.30K 10-K · filed 2024-03-28 |
| 2022-09-30 | $17.03K 10-Q · filed 2023-11-14 | $31.28K derived: sum of 2 quarters · filed 2023-11-14 | $48.01K 10-Q · filed 2023-11-14 | $64.23K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $14.25K 10-Q · filed 2023-08-25 | $30.98K 10-Q · filed 2023-08-25 | $47.20K derived: sum of 3 quarters · filed 2023-08-25 | $63.29K derived: sum of 4 quarters · filed 2023-08-25 |
| 2022-03-31 | $16.73K 10-Q · filed 2023-07-03 | $32.95K derived: sum of 2 quarters · filed 2023-07-03 | $49.04K derived: sum of 3 quarters · filed 2023-07-03 | $69.34K derived: sum of 4 quarters · filed 2023-07-03 |
| 2021-12-31 | $16.22K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $32.31K derived: sum of 2 quarters · filed 2023-06-12 | $52.61K derived: sum of 3 quarters · filed 2023-06-12 | $69.17K 10-K/A · filed 2023-06-12 |
| 2021-09-30 | $16.09K 10-Q · filed 2022-11-14 | $36.39K derived: sum of 2 quarters · filed 2022-11-14 | $52.95K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $20.30K 10-Q · filed 2022-08-15 | $36.87K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $16.57K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |